T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.

Item

http://www.wikidata.org/entity/Q41138074

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

T-replete haploidentical allog ...... and myelodysplastic syndromes.

@en

type

Item

label

T-replete haploidentical allog ...... and myelodysplastic syndromes.

@en

prefLabel

T-replete haploidentical allog ...... and myelodysplastic syndromes.

@en

P1476

T-replete haploidentical allog ...... and myelodysplastic syndromes

@en

P2093

A Granata

http://www.w3.org/2001/XMLSchema#string

B Sarina

http://www.w3.org/2001/XMLSchema#string

C Chabannon

http://www.w3.org/2001/XMLSchema#string

C Faucher

http://www.w3.org/2001/XMLSchema#string

D Blaise

http://www.w3.org/2001/XMLSchema#string

J El-Cheikh

http://www.w3.org/2001/XMLSchema#string

L Morabito

http://www.w3.org/2001/XMLSchema#string

N Vey

http://www.w3.org/2001/XMLSchema#string

P-J Weiller

http://www.w3.org/2001/XMLSchema#string

R Crocchiolo

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Nonparametric Estimation from Incomplete Observations

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Revised international prognostic scoring system for myelodysplastic syndromes.

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.

P2888

bmt.2015.270

P304

194-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.270

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luca Castagna

Carmelo Carlo-Stella

Armando Santoro

P577

2015-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283639489

http://www.w3.org/2001/XMLSchema#string

P6179

1007700236

http://www.w3.org/2001/XMLSchema#string

P698

26551778

http://www.w3.org/2001/XMLSchema#string